Penile prostheses are implanted medical devices used to manage erectile dysfunction (ED). They are meant to provide penis sturdiness, allowing men to accomplish tasks as well as keep an erection. Penile prostheses are accessible in an array of materials, such as malleable as well as inflatable prostheses, and can be semi-rigid or fully rigid. The device is made up of a cylinder implanted in the penis, an injector located in the scrotum, as well as a reservoir situated in the abdomen. Tubing attaches the pump as well as the reservoir, making it possible to inflate or deflate the device as needed.
Penile prostheses are generally utilized as a last resort for men who have not responded to certain other ED treatments, including medications, vacuum erection devices, and injection therapy . The device would be highly effective at trying to restore sexual function, with up to 90% of men satisfied with the procedure. However, there are certain risks involved with penile prostheses, such as infectious disease or a mechanical fault, which means they must be implanted as well as removed surgically.
Erectile dysfunction (ED) is a common condition that affects a large number of men all around the world, especially those over the age of 40. The National Institutes of Health (NIH) predicts that roughly 30 million men in the United States suffer from ED. The pervasiveness of ED rises with age and therefore is associated with a variety of medical conditions, including hyperglycemia, hypertension, and prostate cancer.
Men that haven't responded to certain other forms of ED treatment, such as oral antibiotics, vacuum devices, or blood transfusions, may benefit from penile prostheses. As the pervasiveness of ED continues to rise, there is increasing demand for penile prostheses. Furthermore, technological advances have led to the creation of more efficient and less invasive penile prostheses, which would be expected to drive market growth even further. Inflatable penile prostheses, for instance, that can be inflated and punctured as needed, have enhanced patient happiness and decreased the likelihood of complications. Additionally, rising awareness as well as acceptance of penile prostheses as a treatment option for ED are projected to drive market growth. As the stigma that surrounds ED and penile prostheses fades, more men are likely to look for this type of treatment.
Advanced technologies have led to the creation of penile prostheses with improved designs and materials, such as the inclusion of biodegradable materials and hydraulic systems. These new penile prostheses are sturdier, have fewer problems, as well as provide improved results for patients., as well as acceptance of penile prostheses as just a treatment option for ED,
In addition, minimally invasive surgical techniques for penile prosthesis implantation have been developed, leading to reduced surgical time, shorter hospital stays, and faster recovery times for patients. For example, the use of a small incision or even a single incision approach has been reported to be associated with fewer complications and better cosmetic outcomes compared to traditional surgical techniques. These technological advancements have not only improved the efficacy of penile prostheses but have also reduced the stigma associated with the devices. As more men become aware of the benefits of these new prostheses and surgical techniques, the demand for penile prostheses is expected to increase.
New product launches to flourish in the market
In 2018, Boston Scientific Corporation acquired the privately-held company Augmenix, Inc., which specializes in the development and commercialization of minimally invasive medical devices for the treatment of cancer and other debilitating conditions, including erectile dysfunction. The acquisition was aimed at expanding Boston Scientific's urology and pelvic health portfolio, including its penile implant offering. Additionally, in 2019, Coloplast Corp. announced a strategic partnership with Swiss medical technology company, Humedics AG, to integrate the LiMAx test into its urology product portfolio. The LiMAx test is a non-invasive test that measures the metabolic capacity of the liver, which can help identify patients who are at risk for complications from penile prosthesis surgery.
Segment Overview:
By Type: The penile prostheses market is divided into inflated and non-inflated implants. Inflatable implants are a type of penile prosthesis that consists of two cylinders implanted in the penis and a pump implanted in the scrotum. The cylinders are filled with saline solution, and the pump is used to inflate them, creating an erection. Inflatable implants offer a more natural feel and appearance compared to non-inflatable implants, and they allow for greater control over the duration and firmness of the erection. They are commonly used in the treatment of erectile dysfunction in men who have not responded to other treatments such as medication or non-inflatable implants. Non-inflatable penile prostheses are devices that are implanted into the penis to treat erectile dysfunction. Unlike inflatable prostheses, they do not require the use of a pump or reservoir and are always in a semi-rigid state.
Non-inflatable penile prostheses typically consist of two malleable rods that are surgically implanted into the corpora cavernosa of the penis. The rods can be bent and straightened manually to achieve an erection, and then returned to their natural state when not in use.
By End User: The penile prostheses market is divided into hospitals, ambulatory surgery centers, urology centers, and others.. Hospitals are expected to hold a significant share of the market, owing to the increasing number of hospital admissions for various diseases, including kidney and liver diseases, that require the use of LDH kits for diagnosis and monitoring. Ambulatory surgery centers are also expected to witness growth in the LDH kit market, as these centers provide outpatient surgical services that require the diagnosis and monitoring of various diseases. Urology centers, which specialize in the diagnosis and treatment of urological diseases, are also expected to contribute to the growth of the LDH kit market. Other end-users of LDH kits include pathology laboratories and research institutions.
By Region: The Asia Pacific (APAC) penile prostheses market is expected to experience significant growth in the coming years. Due to the increasing prevalence of diseases that can be diagnosed through LDH testing, the growing demand for point-of-care testing, and advancements in technology, the LDH kit market is expected to experience significant growth in the coming years. Additionally, the focus on preventive healthcare and early diagnosis of diseases is also driving the demand for LDH kits. The LDH kit market is divided into various segments based on factors such as application, type, and end-users.
In the Asia Pacific region, the LDH kit market is expected to grow rapidly due to the increasing prevalence of chronic diseases and a growing elderly population. Overall, the LDH kit market is set to witness significant growth and development in the coming years.
Competitive analysis and profiles of the major players in the lactate dehydrogenase kit market, such as Boston Scientific Corporation, Zephyr Surgical Implants, Coloplast, Promedon, and Rigicon Inc., show that these players have adopted product launch and acquisition as key developmental strategies to improve their product portfolios in the penile prostheses market.
Penile prostheses are generally utilized as a last resort for men who have not responded to certain other ED treatments, including medications, vacuum erection devices, and injection therapy . The device would be highly effective at trying to restore sexual function, with up to 90% of men satisfied with the procedure. However, there are certain risks involved with penile prostheses, such as infectious disease or a mechanical fault, which means they must be implanted as well as removed surgically.
Erectile dysfunction (ED) is a common condition that affects a large number of men all around the world, especially those over the age of 40. The National Institutes of Health (NIH) predicts that roughly 30 million men in the United States suffer from ED. The pervasiveness of ED rises with age and therefore is associated with a variety of medical conditions, including hyperglycemia, hypertension, and prostate cancer.
Men that haven't responded to certain other forms of ED treatment, such as oral antibiotics, vacuum devices, or blood transfusions, may benefit from penile prostheses. As the pervasiveness of ED continues to rise, there is increasing demand for penile prostheses. Furthermore, technological advances have led to the creation of more efficient and less invasive penile prostheses, which would be expected to drive market growth even further. Inflatable penile prostheses, for instance, that can be inflated and punctured as needed, have enhanced patient happiness and decreased the likelihood of complications. Additionally, rising awareness as well as acceptance of penile prostheses as a treatment option for ED are projected to drive market growth. As the stigma that surrounds ED and penile prostheses fades, more men are likely to look for this type of treatment.
Advanced technologies have led to the creation of penile prostheses with improved designs and materials, such as the inclusion of biodegradable materials and hydraulic systems. These new penile prostheses are sturdier, have fewer problems, as well as provide improved results for patients., as well as acceptance of penile prostheses as just a treatment option for ED,
In addition, minimally invasive surgical techniques for penile prosthesis implantation have been developed, leading to reduced surgical time, shorter hospital stays, and faster recovery times for patients. For example, the use of a small incision or even a single incision approach has been reported to be associated with fewer complications and better cosmetic outcomes compared to traditional surgical techniques. These technological advancements have not only improved the efficacy of penile prostheses but have also reduced the stigma associated with the devices. As more men become aware of the benefits of these new prostheses and surgical techniques, the demand for penile prostheses is expected to increase.
New product launches to flourish in the market
In 2018, Boston Scientific Corporation acquired the privately-held company Augmenix, Inc., which specializes in the development and commercialization of minimally invasive medical devices for the treatment of cancer and other debilitating conditions, including erectile dysfunction. The acquisition was aimed at expanding Boston Scientific's urology and pelvic health portfolio, including its penile implant offering. Additionally, in 2019, Coloplast Corp. announced a strategic partnership with Swiss medical technology company, Humedics AG, to integrate the LiMAx test into its urology product portfolio. The LiMAx test is a non-invasive test that measures the metabolic capacity of the liver, which can help identify patients who are at risk for complications from penile prosthesis surgery.
Segment Overview:
By Type: The penile prostheses market is divided into inflated and non-inflated implants. Inflatable implants are a type of penile prosthesis that consists of two cylinders implanted in the penis and a pump implanted in the scrotum. The cylinders are filled with saline solution, and the pump is used to inflate them, creating an erection. Inflatable implants offer a more natural feel and appearance compared to non-inflatable implants, and they allow for greater control over the duration and firmness of the erection. They are commonly used in the treatment of erectile dysfunction in men who have not responded to other treatments such as medication or non-inflatable implants. Non-inflatable penile prostheses are devices that are implanted into the penis to treat erectile dysfunction. Unlike inflatable prostheses, they do not require the use of a pump or reservoir and are always in a semi-rigid state.
Non-inflatable penile prostheses typically consist of two malleable rods that are surgically implanted into the corpora cavernosa of the penis. The rods can be bent and straightened manually to achieve an erection, and then returned to their natural state when not in use.
By End User: The penile prostheses market is divided into hospitals, ambulatory surgery centers, urology centers, and others.. Hospitals are expected to hold a significant share of the market, owing to the increasing number of hospital admissions for various diseases, including kidney and liver diseases, that require the use of LDH kits for diagnosis and monitoring. Ambulatory surgery centers are also expected to witness growth in the LDH kit market, as these centers provide outpatient surgical services that require the diagnosis and monitoring of various diseases. Urology centers, which specialize in the diagnosis and treatment of urological diseases, are also expected to contribute to the growth of the LDH kit market. Other end-users of LDH kits include pathology laboratories and research institutions.
By Region: The Asia Pacific (APAC) penile prostheses market is expected to experience significant growth in the coming years. Due to the increasing prevalence of diseases that can be diagnosed through LDH testing, the growing demand for point-of-care testing, and advancements in technology, the LDH kit market is expected to experience significant growth in the coming years. Additionally, the focus on preventive healthcare and early diagnosis of diseases is also driving the demand for LDH kits. The LDH kit market is divided into various segments based on factors such as application, type, and end-users.
In the Asia Pacific region, the LDH kit market is expected to grow rapidly due to the increasing prevalence of chronic diseases and a growing elderly population. Overall, the LDH kit market is set to witness significant growth and development in the coming years.
Competitive analysis and profiles of the major players in the lactate dehydrogenase kit market, such as Boston Scientific Corporation, Zephyr Surgical Implants, Coloplast, Promedon, and Rigicon Inc., show that these players have adopted product launch and acquisition as key developmental strategies to improve their product portfolios in the penile prostheses market.
Penile Prostheses Market Report Highlights
| Aspects | Details |
 By Type |
|
 By End User |
|
 By Region |
|
 Key Market Players | Boston Scientific Corporation, promedon, Zephyr Surgical Implants, Rigicon Inc., Coloplast |
Loading Table Of Content...
